Showing results (21-30 of 60) with videos related to
Sort By:
Pageof 6
Clinical Pharmacokinetics|March 10, 2019
Revisiting the Pharmacology of Unfractionated HeparinAbdallah Derbalah, Stephen Duffull, Fiona Newall, et al.Journal of Clinical Pharmacology|October 20, 2006
Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysisMette Maja B Teigen, Stephen Duffull, Lily Dang, et al.British Journal of Clinical Pharmacology|September 3, 2011
Population pharmacokinetics and pharmacodynamics of escitalopram in overdose and the effect of activated charcoalFreek van Gorp, Stephen Duffull, L Peter Hackett, et al.British Journal of Clinical Pharmacology|July 11, 2022
Optimal dosing of enoxaparin in overweight and obese childrenAbdallah Derbalah, Stephen Duffull, Catherine M Sherwin, et al.Journal of Pharmacokinetics and Pharmacodynamics|August 10, 2023
Optimal sample selection applied to information rich, dense dataDavid Wang, Tak Hung, Noelyn Hung, et al.Pharmaceutical Research|August 9, 2011
Development and evaluation of a prototype of a novel clotting time test to monitor enoxaparinAbhishek Gulati, James M Faed, Geoffrey K Isbister, et al.The Journal of Pharmacy and Pharmacology|July 29, 2006
Intrasperm Ca2+ modulation and human ejaculated sperm viability: influence of miconazole, clotrimazole and loperamideAbhishek Gulati, Ashok K Tiwary, Subheet Jain, et al.Handbook of Experimental Pharmacology|August 7, 2025
Role of Data in Development and Application of Quantitative Systems Pharmacology ModelsJason R Chan, Abhishek Gulati, Mary E Spilker, et al.Pharmaceutical Research|July 2, 2015
Application of Adaptive DP-optimality to Design a Pilot Study for a Clotting Time Test for EnoxaparinAbhishek Gulati, James M Faed, Geoffrey K Isbister, et al.British Journal of Clinical Pharmacology|March 15, 2016
Development of a population pharmacokinetic-pharmacodynamic model of a single bolus dose of unfractionated heparin in paediatric patientsHesham Al-Sallami, Fiona Newall, Paul Monagle, et al.Pageof 6